BackClinuvel Pharmaceuticals Limited Overview

Clinuvel Pharmaceuticals Limited Operating Income

Latest operating income for CLVLY: $89M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$10.76M
↓ 36.28% YoY

As of Dec 31, 2025

Annual Operating Income (TTM)

$89.29M
↑ 16.15% YoY

Trailing 12 months ending Dec 31, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Clinuvel Pharmaceuticals Limited (CLVLY) FAQ

Clinuvel Pharmaceuticals Limited (CLVLY) currently reports a operating income of $89M as of December 2025. That compares with $77M in the prior-year period — up 16.2% year over year. Use the charts on this page to explore Clinuvel Pharmaceuticals Limited's operating income history and peer comparisons.

Clinuvel Pharmaceuticals Limited's operating income increased from $77M to $89M — a 16.2% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clinuvel Pharmaceuticals Limited reported $89M in operating income as of December 2025. That compares with $77M in the prior-year period — up 16.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $89M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clinuvel Pharmaceuticals Limited, and consider following CLVLY for alerts when major investors trade the stock.

Clinuvel Pharmaceuticals Limited is classified in the Healthcare sector. On operating income, it currently shows $89M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLVLY with unrelated industries.

Questions & Answers